Cytomegalovirus infection: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

  NCT06522880· University of Massachusetts, Worcester· Updated 18 Aug 2026

  “Due to a lack of funding this study was unable to enroll participants.”Registry text, quoted unchanged. Source

• Terminated

  Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection

  NCT05229744· Fondation Ophtalmologique Adolphe de Rothschild· Updated 6 Jan 2026

  “The study was discontinued due to lack of inclusion.”Registry text, quoted unchanged. Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· ModernaTX, Inc.· Updated 15 Dec 2025

  “The Sponsor decided to terminate the study after it did not meet the primary efficacy endpoint at final analysis. The safety profile was consistent with prior studies, and no safety concerns were raised by the Data and Safety Monitoring Board.”Registry text, quoted unchanged. Source

• Terminated

  Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)

  NCT05170269· Biotest· Updated 10 Mar 2025

  “Sponsor decision”Registry text, quoted unchanged. Source

• Terminated

  Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

  NCT05305040· AlloVir· Updated 16 May 2024

  “Study discontinued as DSMB determined it was futile. No safety concerns were noted.”Registry text, quoted unchanged. Source

• Withdrawn

  A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients

  NCT06133010· ModernaTX, Inc.· Updated 15 Mar 2024

  “Trial was cancelled by Sponsor”Registry text, quoted unchanged. Source

• Withdrawn

  A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

  NCT05589844· Roswell Park Cancer Institute· Updated 27 Apr 2023

  “Study never approved”Registry text, quoted unchanged. Source

• Withdrawn

  Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

  NCT02346617· Yae-Jean Kim· Updated 20 Mar 2020

  “Due to the KoreaFDA issue”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

  NCT06677892· Takeda· Source

• A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

  NCT06555432· Takeda· Source

• Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

  NCT05099965· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

  NCT06439342· Takeda· Source

• A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

  NCT06213974· Takeda· Source

• A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection

  NCT06577363· Takeda· Source

• A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

  NCT05089630· GlaxoSmithKline· Source

• CMV-CMI in csCMVi After HSCT

  NCT07688759· The First Affiliated Hospital of Soochow University· Source

• A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

  NCT05319353· Takeda· Source

• HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial

  NCT07570433· Oriol Manuel· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.